Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
D

Diagnos Laboratorium Utama PT Tbk
IDX:DGNS

Watchlist Manager
Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
Watchlist
Price: 304 IDR Market Closed
Market Cap: Rp380B
Write Note Create Alert Ask AI

Profitability Summary

Diagnos Laboratorium Utama PT Tbk's profitability score is 38/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

38/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

38/100
Profitability
Score
38/100
Profitability
Score

Margins

Earnings Waterfall
Diagnos Laboratorium Utama PT Tbk

Margins Comparison
Diagnos Laboratorium Utama PT Tbk Competitors

Country Company Market Cap Gross
Margin 		Operating
Margin 		Net
Margin
ID
Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
380B IDR
Loading...
Loading...
Loading...
US
CVS Health Corp
NYSE:CVS
99.7B USD
Loading...
Loading...
Loading...
US
Cigna Corp
NYSE:CI
78.2B USD
Loading...
Loading...
Loading...
US
Cigna Group
XMUN:CGN
63.5B EUR
Loading...
Loading...
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.9B EUR
Loading...
Loading...
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
23.9B EUR
Loading...
Loading...
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
23B USD
Loading...
Loading...
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
21.3B USD
Loading...
Loading...
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.8B EUR
Loading...
Loading...
Loading...
US
Guardant Health Inc
NASDAQ:GH
12.6B USD
Loading...
Loading...
Loading...
US
DaVita Inc
NYSE:DVA
10B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Diagnos Laboratorium Utama PT Tbk Competitors

Country Company Market Cap ROE ROA ROCE ROIC
ID
Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
380B IDR
Loading...
Loading...
Loading...
Loading...
US
CVS Health Corp
NYSE:CVS
99.7B USD
Loading...
Loading...
Loading...
Loading...
US
Cigna Corp
NYSE:CI
78.2B USD
Loading...
Loading...
Loading...
Loading...
US
Cigna Group
XMUN:CGN
63.5B EUR
Loading...
Loading...
Loading...
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.9B EUR
Loading...
Loading...
Loading...
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
23.9B EUR
Loading...
Loading...
Loading...
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
23B USD
Loading...
Loading...
Loading...
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
21.3B USD
Loading...
Loading...
Loading...
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.8B EUR
Loading...
Loading...
Loading...
Loading...
US
Guardant Health Inc
NASDAQ:GH
12.6B USD
Loading...
Loading...
Loading...
Loading...
US
DaVita Inc
NYSE:DVA
10B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Diagnos Laboratorium Utama PT Tbk

Last Value
3-Years Average
FCF Margin
Conversion Rate

See Also

Summary
DGNS intrinsic value, competitors valuation, and company profile.
DCF Valuation
DGNS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DGNS stock valuation using valuation multiples.
Wall Street Estimates
DGNS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DGNS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 315,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.